Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Maziar Mike Doustdar
Pharma
Novo is open to a direct listing on the New York Stock Exchange
Novo is open to making its shares directly available to increasingly crucial U.S. investors.
Donavyn Coffey
Sep 23, 2026 11:28am
Novo struggles to appease restless investors with new strategy
Sep 21, 2026 10:50am
Novo CEO talks embracing change and staying bullish amid rebrand
Sep 17, 2026 8:45am
Obesity not a winner-takes-all game, Novo CEO says: Reuters
Aug 13, 2026 11:33am
Novo CEO stands firm on guidance amid Wegovy pill sales onslaught
Aug 5, 2026 11:20am
Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce
Jun 11, 2026 7:00am
